Takeda Pharmaceutical Hits Day Low Amid Price Pressure, Closing at JPY 4,861.00

Takeda Pharmaceutical Co., Ltd. experienced a notable decline in its stock performance today, with shares dropping by 4.63% as of June 1, 2026. The stock reached an intraday low of JPY 4,861.00, reflecting a challenging trading environment. In terms of performance metrics, Takeda's one-day performance contrasts sharply with the Japan Nikkei 225, which gained 0.91%. Over the past week, the stock has decreased by 4.37%, while its one-month performance shows a decline of 6.83%. Despite a positive year-over-year performance of 13.14%, the stock has struggled in the shorter term, with year-to-date growth at just 0.95%. Financially, Takeda is net-debt free, but it has reported a low Return on Capital Employed (ROCE) of 5.23%, indicating challenges in profitability relative to its capital. The company has seen a healthy long-term growth rate in net sales of 6.89%, although operating profit growth has been modest at 2.47%. With a market capitalization of JPY 8,143,911 million, Takeda remains a significant player in the pharmaceuticals and biotechnology sector, despite current market pressures.